Galectin-8: a matricellular lectin with key roles in angiogenesis
- PMID: 24939370
- DOI: 10.1093/glycob/cwu054
Galectin-8: a matricellular lectin with key roles in angiogenesis
Abstract
Galectin-8 (gal-8) is a "tandem-repeat"-type galectin, containing two carbohydrate recognition domains connected by a linker peptide. gal-8 is expressed both in the cytoplasm and nucleus in vascular endothelial cells (ECs) from normal and tumor-associated blood vessels, and in lymphatic endothelial cells. Herein, we describe a novel role for gal-8 in the regulation of vascular and lymphatic angiogenesis and provide evidence of its critical implications in tumor biology. Functional assays revealed central roles for gal-8 in the control of capillary-tube formation, EC migration and in vivo angiogenesis. So far, two endothelial ligands have been described for gal-8, namely podoplanin in lymphatic vessels and CD166 (ALCAM, activated leukocyte cell adhesion molecule) in vascular ECs. Other related gal-8 functions are also summarized here, including cell adhesion and migration, which collectively demonstrate the multi-functionality of this complex lectin. Thus, gal-8 is an important component of the angiogenesis network, and an essential molecule in the extracellular matrix by providing molecular anchoring to this surrounding matrix. The implications of gal-8 in tumor angiogenesis remain to be further explored, but it is exciting to speculate that modulating gal-8-glycan interactions could be used to block lymphatic-vascular connections vital for metastasis.
Keywords: CD166; angiogenesis; endothelium; galectin-8.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8.FASEB J. 2011 Jan;25(1):242-54. doi: 10.1096/fj.09-144907. Epub 2010 Sep 27. FASEB J. 2011. PMID: 20876211
-
Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells.Biochim Biophys Acta. 2016 Oct;1860(10):2255-68. doi: 10.1016/j.bbagen.2016.04.019. Epub 2016 Apr 26. Biochim Biophys Acta. 2016. PMID: 27130882
-
Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.Biochim Biophys Acta Mol Cell Res. 2019 Aug;1866(8):1338-1352. doi: 10.1016/j.bbamcr.2019.03.010. Epub 2019 Mar 21. Biochim Biophys Acta Mol Cell Res. 2019. PMID: 30905597
-
Galectin-1 and -9 in angiogenesis: a sweet couple.Glycobiology. 2014 Oct;24(10):915-20. doi: 10.1093/glycob/cwu048. Epub 2014 May 26. Glycobiology. 2014. PMID: 24861051 Review.
-
Galectins and neovascularization in central nervous system tumors.Glycobiology. 2014 Oct;24(10):892-8. doi: 10.1093/glycob/cwu049. Epub 2014 May 26. Glycobiology. 2014. PMID: 24861052 Review.
Cited by
-
Galectin-8 and -9 as prognostic factors for cervical cancer.Arch Gynecol Obstet. 2022 Oct;306(4):1211-1220. doi: 10.1007/s00404-022-06449-9. Epub 2022 Apr 4. Arch Gynecol Obstet. 2022. PMID: 35377045 Free PMC article.
-
Activated leukocyte cell adhesion molecule/cluster of differentiation 166 rs10933819 (G>A) variant is associated with familial intracranial aneurysms.Biomed Rep. 2022 Jun 7;17(2):65. doi: 10.3892/br.2022.1548. eCollection 2022 Aug. Biomed Rep. 2022. PMID: 35815187 Free PMC article.
-
Galectins: Important Regulators in Normal and Pathologic Pregnancies.Int J Mol Sci. 2022 Sep 3;23(17):10110. doi: 10.3390/ijms231710110. Int J Mol Sci. 2022. PMID: 36077508 Free PMC article. Review.
-
The role of galectins‑1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer (Review).Mol Med Rep. 2022 May;25(5):166. doi: 10.3892/mmr.2022.12682. Epub 2022 Mar 16. Mol Med Rep. 2022. PMID: 35293602 Free PMC article.
-
Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine.Front Pharmacol. 2023 Mar 7;14:1147717. doi: 10.3389/fphar.2023.1147717. eCollection 2023. Front Pharmacol. 2023. PMID: 36959862 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous